Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2000
11/02/2000EP0822991A4 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus
11/02/2000EP0784626A4 Novel protein marker and dna encoding same
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000DE19919205A1 Diagnostischer Marker für das Humanherz Diagnostic marker for the human heart
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2371006A1 Protein-protein interactions
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370442A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity
11/02/2000CA2370351A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000CA2370298A1 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/01/2000CN1272139A Nucleic acids coding for proteins capable of interacting with presenilins
10/2000
10/31/2000US6140530 Quinidine conjugates and their use in immunoassays
10/31/2000US6140492 Antisense transcript expressed in B lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
10/31/2000US6140488 Ras-binding protein (PRE1)
10/31/2000US6140474 Monoclonal antibody reactive with human-origin CETP and method of quantifying human-origin CETP
10/31/2000US6140473 Antibodies specific for MTS2 Polypeptide
10/31/2000US6140471 Methods for producing members of specific binding pairs
10/31/2000US6140470 Human monoclonal anti-tumor antibodies
10/31/2000US6140468 Obtained by recombinant dna technology using baculovirus expression system; has defined n-terminal amino acid sequence; does not complex with alpha-1-antichymotrypsin or alpha-2-macroglobulin; does not degrade specific substrates
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140305 Hereditary hemochromatosis gene products
10/31/2000US6140128 Mixing calcium divalent cation, phosphate multivalent anion and the desired nucleic acid to form precipitation mixture, then incubating for 10 to 60 minutes to form particles
10/31/2000US6140117 Ninjurin
10/31/2000US6140116 Adjusted swine neuronal cells for the treatment of humans with stroke, brain trauma, amyotrophic lateral sclerosis, multiple sclerosis, huntington's and alzheimer's disease
10/31/2000US6140098 Nucleic acids encoding mammalian proteinases; related reagents
10/31/2000US6140093 Nucleotide sequences coding an enzymatic protein for use as an antidote in organophorphous insecticide poisoning and to prevent neuronal cell
10/31/2000US6140091 Anti-idiotype vaccines to elicit catalytic antibodies
10/31/2000US6140086 Methods and compositions for cloning nucleic acid molecules
10/31/2000US6140075 Method for producing antibodies and protein toxins in plant cells
10/31/2000US6140061 Response regulator
10/31/2000US6140058 Activation of p53 protein
10/31/2000US6140043 Pharmaceutical composition comprising a protein, peptide or a functionally equivalent molecule
10/31/2000US6139869 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000US6139843 Administering a polypeptide conjugate compositions to enhance immunogenicity, for treatment and prevention of viral infections
10/31/2000US6139840 Administering a therapeutic compositions to protect a host animal from flea infestation
10/31/2000US6139839 Administering to warm-blooded animal an effective amount of an immunotherapy agent that binds to and inhibits the growth-regulating activity of chorionic gonadotropin-like growth-regulating protein of infectious microorganism
10/31/2000CA2197684C Human-murine chimeric antibodies against respiratory syncytial virus
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2175451C Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
10/31/2000CA2160780C Cold-tolerant strains of rhizobium species
10/26/2000WO2000063700A1 Monoclonal antibodies reactive with fibrin(ogen) degradation products generated by matrix metalloproteinases
10/26/2000WO2000063699A1 A tenascin-c isoform as a marker for neoplasias
10/26/2000WO2000063692A1 Secreted proteins and polynucleotides encoding them
10/26/2000WO2000063444A2 Method for detecting hepatitis c virus with hybridomas
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063435A2 Method of identifying toxic agents using differential gene expression
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063382A1 Genes and expression products from hematopoietic cells
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063377A1 Adipocyte complement related protein homolog zacrp3
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063358A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063252A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063250A1 Antibodies that recognize app cleaved by caspases and methods of use
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063244A1 Parasite antigens
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000062817A2 Inducible vaccines
10/26/2000WO2000062815A2 Novel pharmaceutical composition suitable for gene therapy
10/26/2000WO2000062807A1 Diagnosis and treatment of neuroectodermal tumors
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062803A2 ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS
10/26/2000WO2000062795A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000WO2000062735A2 Treatment of neoplasms with viruses
10/26/2000WO2000062626A1 Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
10/26/2000WO2000040719A3 Tissue repair protein involved in orofacial clefting and uses thereof
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000036135A3 Screening methods based on the use of protein kinases
10/26/2000WO2000036108A3 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000025808A8 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
10/26/2000WO2000025574A9 Production of biomedical peptides and proteins in plants using plant virus vectors
10/26/2000WO2000023806A9 Detection and quantification of vancomycin in biological fluids
10/26/2000WO2000018795A3 Compositions and methods for wt1 specific immunotherapy
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370609A1 Adipocyte complement related protein homolog zacrp3
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370144A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 1494